CLASS II Drug recall · Reported 4 Jul 2012 · FDA Enforcement Report
Thyro-Tab 0.050mg recalled by Lloyd
Lloyd is recalling Thyro-Tab 0.050mg, distributed nationwide in the US. The recall was initiated on 3 Feb 2012 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1392-2012
- FDA event ID
- 61094
- Recalling firm
- Lloyd, Shenandoah, IA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 3 Feb 2012
- FDA classified
- 22 Jun 2012
- Reported
- 4 Jul 2012
- Type
- Voluntary: Firm initiated
- Customers notified by
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Reason category
- Potency & Assay
Timeline
| 3 Feb 2012 | Recall initiated by company | |
| 22 Jun 2012 | Classified by FDA | +140 days |
| 4 Jul 2012 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Where it was distributed
Nationwide and PR.
Questions about this recall
Why was it recalled?
Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
Which lots are affected?
Lot HB06311
Where was it sold?
Nationwide and PR.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 61094| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Levothroid (levothyroxine sodium tablets, USP), 50 mcg recalled by Lloyd | Lloyd | Potency & Assay | Nationwide |
More recalls from Lloyd
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Levothroid (levothyroxine sodium tablets, USP), 50 mcg recalled by Lloyd | Lloyd | Potency & Assay | Nationwide |
| Drug | CLASS II | Levothroid (levothyroxine sodium tablets, USP), 75 mcg recalled by Lloyd | Lloyd | Potency & Assay | Nationwide |
| Drug | CLASS II | Thyro-Tab.075 mg recalled by Lloyd | Lloyd | Potency & Assay | Nationwide |
Other Thyro-tab recalls
All 10| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Thyro-Tab 0.050 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Thyro-Tab 0.075 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Thyro-Tab 0.088 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Thyro-Tab 0.300 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Thyro-Tab 0.125 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Manufacturing (CGMP) Deviations | Nationwide |